| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/19/2008 | CN101306149A Diabetes treating medicine |
| 11/19/2008 | CN101306142A Yangxuemeiyan capsule |
| 11/19/2008 | CN101306139A Quality control method of Biyan Qingdu granule |
| 11/19/2008 | CN101306136A Capsules for treating uremia |
| 11/19/2008 | CN101306135A Avian influenza prevention powder |
| 11/19/2008 | CN101306134A Compound Nanxing pain paste and cataplasm combination and its preparation method |
| 11/19/2008 | CN101306133A Oral liquid for anti-AIDS |
| 11/19/2008 | CN101306131A Duituizidian pill |
| 11/19/2008 | CN101306130A Sanjialongdan Ruangan pill |
| 11/19/2008 | CN101306129A Chinese herbal medicine compound preparation for treating hypertension and its preparation method |
| 11/19/2008 | CN101306124A Quick-acting antidiarrheal granule and its preparation method |
| 11/19/2008 | CN101306120A Chinese caterpillar fungus kidney reinforce mixture |
| 11/19/2008 | CN101306119A Nicandra physalodes decoction for treating urgent, chronic prostate disease |
| 11/19/2008 | CN101306118A Xuekangfu pill |
| 11/19/2008 | CN101306117A Production of Qufu powder and Shengjizhangpi paste and evodia fruit paste |
| 11/19/2008 | CN101306112A Baimaiyutong paster |
| 11/19/2008 | CN101306105A Medicament for preventing and treating puerperal hypogalactia |
| 11/19/2008 | CN101306103A Medicine composition containing morinda root oligosacchride and its preparation method |
| 11/19/2008 | CN101306097A Zengkangning tablets quality control method |
| 11/19/2008 | CN101306091A Use of prince feather and fleabane combination in preparing medicament for treating kidney disease |
| 11/19/2008 | CN101306086A Broussonetia papyrifera leaves health obesity attenuation capsule and its preparation method |
| 11/19/2008 | CN101306082A Houkangsan quality control method |
| 11/19/2008 | CN101306081A Xinshuning tablets quality control method |
| 11/19/2008 | CN101306080A Elsholtzia spray |
| 11/19/2008 | CN101306077A Chinese traditional injection preparation for treating cancer and its preparation method |
| 11/19/2008 | CN101306074A Anti-alcohol and liver- protection medicine composition |
| 11/19/2008 | CN101306072A Gadol buccal tablet and its preparation method |
| 11/19/2008 | CN101306030A Compound breviscpini soft capsule and its preparation method |
| 11/19/2008 | CN101306029A Hydroxypropyl¿Cbelta-cyclodextrin inclusion compound of Chinese angelica volatile oil, its preparation method and use |
| 11/19/2008 | CN101306028A Use of asafetida volatile oil in preparing anticancer medicine |
| 11/19/2008 | CN101306025A Hydroxypropyl¿Cbelta-cyclodextrin inclusion compound of brucea fruit volatile oil, its preparation method and use |
| 11/19/2008 | CN101306019A Hyper-concentrated placenta nano viable cell freeze-drying capsules and its preparation method |
| 11/19/2008 | CN101306018A Hyper-concentrated placenta tissue hydrolysate freeze-drying capsules and its preparation method |
| 11/19/2008 | CN101306017A Hyper-concentrated placenta lipopolysaccharide freeze-drying capsules and its preparation method |
| 11/19/2008 | CN101306015A Composition for increasing embryo quality and preventing and curing defect baby from generating |
| 11/19/2008 | CN101305996A Compound domperidone dimethicone dispersible tablet and its preparation method |
| 11/19/2008 | CN101305995A Sustained release preparation containing domperidone pantoprazole sodium and its preparation method |
| 11/19/2008 | CN101305994A Minimizing adverse experience associated with oxybutynin therapy |
| 11/19/2008 | CN101305992A Compound sustained-released injection containing neonatal blood vessel restraining agent |
| 11/19/2008 | CN101305991A Compound sustained-released injection containing neonatal blood vessel restraining agent |
| 11/19/2008 | CN101305989A Yibosu capsule and its preparation method |
| 11/19/2008 | CN101305988A Compound alendronate sodium vitamine D3 orally disintegrating tablets and preparation method thereof |
| 11/19/2008 | CN101305987A Compound gabapentin mecobalamin dispersible tables and preparation method thereof |
| 11/19/2008 | CN101305986A Lafutidine Tablet and its preparation method |
| 11/19/2008 | CN101305985A Preparation method of coffee acid polylactic acid copolymer nanometer microsphere |
| 11/19/2008 | CN101305984A Medicaments solution |
| 11/19/2008 | CN101305983A Nanometer Ag antibiotic gent for women and its preparation method |
| 11/19/2008 | CN101305982A 局部凝胶给药体系 Topical gel delivery system |
| 11/19/2008 | CN101305766A Active yam protein powder and its production method |
| 11/19/2008 | CN100434462C Thin film contg. starch |
| 11/19/2008 | CN100434133C Antisolvent solidification process |
| 11/19/2008 | CN100434120C Amphipathic fluorescence target nano micelle and its preparation method |
| 11/19/2008 | CN100434117C Suppository for treating chronic cervicitis |
| 11/19/2008 | CN100434115C Powder containing tuckahoe, seed of gordon euryale, coix seed and lotus seed |
| 11/19/2008 | CN100434111C Powder containing seed of spine date, licorice and wheat |
| 11/19/2008 | CN100434110C Powder comprising mint and chrysanthemum |
| 11/19/2008 | CN100434100C Medicine, food used article for preventing and curing chronic diarrhoea and method for producing the same |
| 11/19/2008 | CN100434099C Medicinal composition for diabete and its making method |
| 11/19/2008 | CN100434097C Ophidia black snake powder |
| 11/19/2008 | CN100434095C Medicine for treating facial nerve paralysis |
| 11/19/2008 | CN100434093C 'Kidney-Benefiting' glucose injection and its preparing process |
| 11/19/2008 | CN100434092C Prescription containing sweet clover component and its formulation |
| 11/19/2008 | CN100434091C Fenugreek seed extract and its preparing process and application |
| 11/19/2008 | CN100434090C Alginic nutrient capsules and preparation thereof |
| 11/19/2008 | CN100434089C Use of centipeda volatile oil in preparation of tumor growth and proliferation inhibitor |
| 11/19/2008 | CN100434088C Intravenous administration preparation extracted from marsdenia tenacissima stem |
| 11/19/2008 | CN100434087C Compound oral prepn of muskone and total arasaponin and its application |
| 11/19/2008 | CN100434084C Pharmaceutical composition for treating rheumatic and rheumatoid diseases and its preparation process |
| 11/19/2008 | CN100434083C Medicinal use of fugu cod liver oil |
| 11/19/2008 | CN100434081C Medicine for treating anal and bowel pile |
| 11/19/2008 | CN100434080C A medicine for treating dermatosis |
| 11/19/2008 | CN100434078C Ambroxol hydrochloride compound slow-release tablet and its preparing method |
| 11/19/2008 | CN100434077C Megestrol acetate capsule composition |
| 11/19/2008 | CN100434076C Compounding prepn. contg. cefteram pivoxil and pidotimod |
| 11/19/2008 | CN100434075C Usage of caffeine and its analogue in resistance of hepatitis B replication and use thereof in preparation of medicament for treating viral hepatitis |
| 11/19/2008 | CN100434074C Use of chloride 13-hexyl berberine and chloride 13-hexyl palmatine in preparation of medicine for treating skin mucosa herpes viral infection |
| 11/19/2008 | CN100434073C Use of chloride 13-hexyl berberine in preparation of medicine for treating peptic ulcer and bacteriological gastroenteritis |
| 11/19/2008 | CN100434070C Externally applied ointment of ketorolac tromethamine and its preparation method |
| 11/19/2008 | CN100434069C Stable compositions of atorvastatin prepared with wet granulation |
| 11/19/2008 | CN100434068C Bexarotene gel and its preparation method |
| 11/19/2008 | CN100434066C Curcuma longa extract injection, and preparing process and use thereof |
| 11/19/2008 | CN100434065C Hemostatic preparation for gynecology department |
| 11/19/2008 | CN100434064C Pharmaceutical composition for treating qi and blood deficiency and its preparation method |
| 11/19/2008 | CN100433988C Chewing gum formulations including encapsulated aspartame and sodium pyrophosphate |
| 11/18/2008 | US7452936 Adhesive compounds of butyl-type rubber |
| 11/18/2008 | US7452917 Emulsions made from particular emulsifers |
| 11/18/2008 | US7452916 Administering arginine, lysine; cardiovascular disorder therapy |
| 11/18/2008 | US7452868 provides release for a period of at least about two months; treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas |
| 11/18/2008 | US7452864 chronic ulcers; cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media |
| 11/18/2008 | US7452860 Zinc-free and low-zinc insulin preparations having improved stability |
| 11/18/2008 | US7452679 Hybridization; phage display; spectroscopy |
| 11/18/2008 | US7452554 Platinum nanocolloid solution, process for producing the same and drink containing platinum nanocolloid |
| 11/18/2008 | US7452553 Dietary fiber delivery system |
| 11/18/2008 | US7452551 Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a perfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image |
| 11/18/2008 | US7452550 Providing liposome having free active agent and precipitated active agent encapsulated therein; varying amount of active agent that is precipitated in liposome for modulation plasma circulation half-life of active agent |
| 11/18/2008 | US7452525 demonstrates excellent adhesion to hair; significantly less or no flaking at all; provides improved humidity retention, higher luster and natural feel |
| 11/18/2008 | US7452524 Method for improvement of tolerance for therapeutically effective agents delivered by inhalation |
| 11/18/2008 | US7452523 Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks |
| 11/18/2008 | CA2517141C Method to produce a solid form of heparin |
| 11/18/2008 | CA2469369C Compositions containing both sedative and non-sedative antihistamines |